Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sonoma Biotherapeutics
Biotech
Regeneron to take $56M IPR&D hit in Q1
Regeneron anticipates a $56 million hit tied to IPR&D costs for its freshly inked deal with Sonoma Biotherapeutics.
Gabrielle Masson
Apr 10, 2023 2:40pm
Biotech's top 10 money raisers of 2021
Apr 18, 2022 3:00am
Sonoma Bio bags $265M for arthritis, diabetes cell therapies
Aug 4, 2021 7:00am
Sonoma bags $40M to push Tregs for autoimmune, neuro diseases
Feb 6, 2020 11:05am
